Illumina (XTER:ILU) Net Change in Cash : €-54 Mil (TTM As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Illumina Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Illumina's Net Change in Cash for the three months ended in Sep. 2024 was €-46 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 was €-54 Mil.

Illumina Net Change in Cash Historical Data

The historical data trend for Illumina's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Net Change in Cash Chart

Illumina Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

808.20

-190.70

-511.53

735.38

-883.07

Illumina Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Change in Cash	Get a 7-Day Free Trial															-586.56	110.96	55.20	-174.65	-45.95

Illumina Net Change in Cash Calculation

Illumina's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	438.326	+	-211.827	+	-1109.57	+	0
	=	-883

Illumina's Net Change in Cash for the quarter that ended in Sep. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 284.716 + -36.941 + -299.132 + 5.406

= -46

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Illumina Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Illumina's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Illumina Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (XTER:ILU) » Definitions » Net Change in Cash

Comparable Companies

WAT NTRA LH MTD DGX ICLR RVTY MEDP IDXX CRL TMO DHR XSWX:LONN A IQV SHSE:603259 XPAR:BIM EXAS QGEN XPAR:ERF

Traded in Other Exchanges

ILMN:USA ILMN:Mexico 1ILMN:Italy 0J8Z:UK ILU:Germany ILU:Germany I1LM34:Brazil ILMN:Austria

Address

5200 Illumina Way, San Diego, CA, USA, 92122

Website

https://www.illumina.com

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina Headlines

No Headlines